NCT02351765View on ClinicalTrials.gov

ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Biliary Tract CancerGallbladder CancerCholangiocarcinomaAmpullary Cancer
Interventions
DRUG

Acelarin

First-in-class nucleotide analogue

DRUG

Cisplatin

Platinum-compound chemotherapy drug

Trial Locations (5)

Unknown

Beatson Oncology Centre, Glasgow

Clatterbridge Cancer Centre, Liverpool

Imperial College London, London

University College London, London

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
lead

The Christie NHS Foundation Trust

OTHER

NCT02351765 - ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers | Biotech Hunter | Biotech Hunter